Abstract: The present invention concerns a nuclear inhibitor which specifically inhibits the activity of sequence specific DNA enhancer binding proteins of Human Papilloma Virus (HPV) and the use of this nuclear inhibitor for the production of a medicament for treatment of human cervical cancer.

Abstract: In fluorescence analysis of multiply stained particles, particularly biological cells, in a continuous flowthrough procedure, in which the particles are suspended in a carrier fluid, the carrier fluid containing the suspended particles is encased in a sheath stream, the resulting composite stream is conducted in laminar flow through an intensive laser light zone where fluorescent light pulses are generated by the action of the laser light on the particles and emanate from the particles, and those fluorescent pulses are detected and processed in real time in an electronic evaluation system, the laser light zone is produced by focussing at least two laser beams of respectively different wavelengths on two points spaced at a given distance apart along the path of the particle-containing fluid in the composite stream, and the detection and processing is effected by correlating the fluorescence pulses emanating from the two points on the basis of the spacing between the two points and of the flow speed of the stre